BRIEF published on 09/08/2025 at 22:05, 6 months 13 days ago Abivax publie ses résultats financiers du premier semestre 2025 Résultats Financiers Obligations Convertibles Recherche Et Développement Offre Publique Réserves De Trésorerie
PRESS RELEASE published on 09/08/2025 at 22:00, 6 months 13 days ago Abivax présente ses résultats financiers du premier semestre 2025 Abivax présente ses résultats financiers du premier semestre 2025, avec une perte nette de 100,8 millions d'euros. Principalement axée sur le développement de thérapies pour les maladies inflammatoires Résultats Financiers Abivax Perte Nette Thérapies Premier Semestre 2025
PRESS RELEASE published on 09/08/2025 at 22:00, 6 months 13 days ago Abivax Presents First Half 2025 Financial Results Abivax presents first half 2025 financial results, revealing operating loss increase and net loss for the period, also updates on clinical programs and public offering Financial Results Abivax Public Offering Clinical Programs Operating Loss
BRIEF published on 09/02/2025 at 11:00, 6 months 19 days ago JP Morgan Chase & Co. Crosses Threshold at ABIVAX Voting Rights Capital Abivax Threshold Crossing JP Morgan
BRIEF published on 09/02/2025 at 11:00, 6 months 19 days ago Franchissement de seuil par J.P. Morgan Chase & Co. chez ABIVAX Capital Droits De Vote Franchissement De Seuil Abivax J.P. Morgan
PRESS RELEASE published on 09/02/2025 at 10:55, 6 months 19 days ago Franchissement de seuil Déclaration de franchissement de seuil de 5% du capital de la société ABIVAX par la société J.P. Morgan Chase & Co. indirectement, le 28 août 2025 Déclaration Franchissement De Seuil Abivax 5% J.P. Morgan Chase
BRIEF published on 08/13/2025 at 18:05, 7 months 8 days ago ABIVAX : Mise à jour sur le capital et les droits de vote Euronext Paris Droits De Vote Capital Social AMF Abivax
BRIEF published on 08/13/2025 at 18:05, 7 months 8 days ago ABIVAX: Update on capital and voting rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 08/13/2025 at 18:05, 7 months 8 days ago ABIVAX: Share and voting rights data as of July 31, 2025 Euronext Paris Voting Rights Biotechnology Actions AMF Regulations
BRIEF published on 08/13/2025 at 18:05, 7 months 8 days ago ABIVAX: Données sur les actions et droits de vote au 31 juillet 2025 Euronext Paris Droits De Vote Biotechnologie Actions Réglementation AMF
Published on 03/20/2026 at 13:30, 1 day 21 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 22 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 1 day 11 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 13 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 13 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 13 hours ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 14 hours ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 1 day 15 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 15 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 16 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 16 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
